Aflibercept (40 mg/ml)

Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha·Praha - Břevnov, Czech Republic·CZK 50.1M | EUR 2.1M·Expired · Sep 15, 2026·Open·Supplies

Inscrivez-vous pour sauvegarder Open documents

High valueStructured notice only

Titre original de l'avis

Czechia – Ophthalmologicals – Aflibercept (40 mg/ml)

55/100

Score d'opportunité

Needs reviewLow complexity

SuppliesExpired

Pourquoi ce score ?

Opportunité

55 / 100

Complexité

25 / 100

Facteurs de risque

Procurement documents not analyzed. Essential terms, conditions, and technical specifications unknown.

Structured data indicates EU-funded (isEuFunded: true) but XML notice states no EU funds (FundingProgramCode: no-eu-fun...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Informations clés

Pouvoir adjudicateur: Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha
Pays: République tchèque
CPV: 33662100 - Ophthalmologicals
Date limite: Sep 15, 2026
Valeur estimée: CZK 50.1M (approx. EUR 2.1M)

Aperçu

Moderate opportunity

Faits clés

CZK 50.1M estimated value
Supplies contract
1 lot
Duration 48 MONTH
Continuous supplies of Aflibercept (40 mg/ml) for 48 months.
Delivery to Central Military Hospital – Military University Hospital Prague.

Afficher le résumé complet

Open tender by Ústřední vojenská nemocnice – Vojenská fakultní nemocnice Praha for continuous supplies of the medicinal product with active substance Aflibercept (40 mg/ml) for a period of 48 months. The estimated value is 50,148,102.56 CZK. Award based on lowest price. No selection criteria or procurement documents provided in the analysis.

Risques

Procurement documents not analyzed. Essential terms, conditions, and technical specifications unknown.

Structured data indicates EU-funded (isEuFunded: true) but XML notice states no EU funds (FundingProgramCode: no-eu-fun...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

Pharmaceutical product with active substance Aflibercept at concentration 40 mg/ml.
Contract duration 48 months.
EU-funded project (conflicting: XML notice states no EU funds).

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

Lowest price (weight 100) — 100%

Acheteur

Nom

Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha

Localisation

Praha - Břevnov, CZE

[email protected]

Site web

www.uvn.cz

Profil acheteur

Ouvrir le profil

Identifiant

61383082

Activité

Health

Lots (1)

LOT-0001